This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John R. Stephenson, MD
Honolulu

JAMA. 1970;213(6):1040.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Several strains of rubella vaccine have proved effective in stimulating antirubella antibodies and presumably imparting protection against infection with wild rubella virus in humans. Since these vaccines have been licensed, many parts of our country are in the process of mass immunization of prepubertal boys and girls in order to induce immunity in these individuals and reduce the potential for an epidemic spread to susceptible adolescents and young adults.

As commendable as this program is, it leaves a large group of susceptible persons unimmunized and unprotected. Indeed, the US Public Health Service and the American Academy of Pediatrics have cautioned against the use of these live vaccines in postpubertal children and young adults for two reasons: the higher incidence of arthritis and arthralgia in older persons, and the concern that the vaccine strain of virus might pass the placental vaccines in a recipient who is or becomes . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?